Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

Aviptadil.

Research draft

Aviptadil is synthetic vasoactive intestinal peptide.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Aviptadil is synthetic vasoactive intestinal peptide.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It affects VIP receptors involved in vascular, secretory and immune signalling.

Human research

Randomised respiratory studies exist; TESICO did not establish its intended clinical benefit. Other trial findings must not erase that result.

Preclinical & other research

Laboratory work investigated lung and inflammatory responses.

Safety & unknowns

Haemodynamic and gastrointestinal effects require attention in the studied route and clinical setting.

Regulatory status

Cross-link VIP; no general respiratory or wellness approval is established by these trials.

Reported use & evidence

Research profile draft

The supplied Aviptadil profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds